[spacer image]
BD
[spacer image]
About
[spacer image]
News
[spacer image]
Resource Center
[spacer image]
Events
[spacer image]
Products
[spacer image]
MRSA Resource Kit
[spacer image]
Contact Us
[spacer image]
HAIs Home
[spacer image]
[spacer image]

News & Events
Email Page Print
[spacer image]

July 07, 2008
BD Announces CE Marking of a New Molecular Test to Diagnose Patients with Clostridium difficile Infections

June 10, 2008
BD Celebrates Opening of New Manufacturing Center in Québec
June 02, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

May 01, 2008
BD Announces CE Marking of the BD GeneOhm™ VanR Molecular Test for the Rapid Detection of Vancomycin Resistance

April 07, 2008
Preliminary Data from Pitt County Memorial Hospital Study Show Benefit of Active Surveillance on Reducing MRSA VAP Rates in Surgical ICU
March 17, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates

January 02, 2008
BD Announces FDA 510(k) Clearance of Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures

December 20, 2007
BD Announces CE Marking of Rapid Molecular Test to Identify Superbug from Nasal and Wound Specimens

December 18, 2007
UCLH Study Demonstrates Rapid Patient Screening Could Cut MRSA Rates By Almost 40 Per Cent
November 05, 2007
BD Sponsors New Tool to Combat MRSA Infections in Hospitals
October 22, 2007
CEO Ed Ludwig Discusses Healthcare-associated Infections on CNBC (Video)
October 04, 2007
Screening for Nasal Carriage of MRSA: Reduction of Turnaround Time and Workload by the use of BD BBL™ CHROMagar™ MRSA
September 12, 2007
BD GeneOhm's Flagship Client, Evanston Northwestern Healthcare, Receives Prestigious Patient Safety Award from the NQF and the Joint Commission for its MRSA Prevention Program
June 25, 2007
APIC Announces MRSA Prevalence Study Results
May 23, 2007
BD Demonstrates Microbiology Automation Designed to Improve Laboratory Efficiency of Microbial Identification and Susceptibility Testing
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
May 21, 2007
BD Receives CE Mark Approval for Two-Hour Test to Identify Superbug in Patients with Positive Blood Cultures
April 25, 2007
BD Announces FDA 510(k) Submission of Two Hour Test to Identify Superbug in Patients with Positive Blood Cultures
February 09, 2007
BD Helping APIC to Expand its Mission in HAIs Prevention at the APIC Futures Summit (PDF)
December 01, 2006
Evanston Northwestern Healthcare Study Shows Benefit of Universal Surveillance (PDF)
December 01, 2006
Evanston Northwestern Healthcare Study Reveals Who is Most at Risk for Carrying MRSA (PDF)
December 01, 2006
"Grand Rounds" Address Impact of Antibiotic-Resistant Superbug on Healthcare Facilities (PDF)
[spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image] [spacer image] [spacer image]
[spacer image]
Site Map
Privacy | Terms & Conditions | Permission Request | Trademarks
BD Worldwide
BD
1 Becton Drive
Franklin Lakes, NJ USA 07417
201.847.6800
Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2008 BD